Market

Delhi HC upholds MSD’s Sitagliptin patent

Read more

India, UK health regulators sign MoU

Read more

Pharma sector growth likely to remain strong: ICRA

Read more

DoP recommends foolproof system to curb adverse drug reactions

Read more

Novartis launches access programme for 15 medicines

Read more

US FDA reverses NDA nod for Sun Pharma’s anti epileptic drug

Read more

Ajanta Pharma in NSE’s Nifty Midcap 50 index

Read more

Department of Pharmaceuticals’ revamped website launched

Read more

Dr Reddy’s, BioMarin settle patent litigation on Kuvan tablets

Read more

Pfizer to sell its Thane plant to Vidhi Research and Development

Read more